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In the fission yeast Schizosaccharomyces pombe, rasl regulates both sexual development (conjugation and
sporulation) and cellular morphology. Two types of dominant interfering mutants were isolated in a genetic
screen for rasi mutants that blocked sexual development. The first type of mutation, at Ser-22, analogous to
the H-rasAsnl7 mutant (L. A. Feig and G. M. Cooper, Mol. Cell. Biol. 8:3235-3243, 1988), blocked only
conjugation, whereas a second type of mutation, at Asp-62, interfered with conjugation, sporulation, and
cellular morphology. Analogous mutations at position 64 of Saccharomyces cerevisiae RAS2 or position 57 of
human H-ras also resulted in dominant interfering mutants that interfered specifically and more profoundly
than mutants of the first type with RAS-associated pathways in both S. pombe or S. cerevisiae. Genetic evidence
indicating that both types of interfering mutants function upstream of RAS is provided. Biochemical evidence
showing that the mutants are altered in their interaction with the CDC25 class ofexchange factors is presented.
We show that both H-rasAn'17 and H-rasTyr5s7, compared with wild-type H-ras, are defective in their guanine
nucleotide-dependent release from human cdc25 and that this defect is more severe for the H-ras Tyr-57 mutant.
Such a defect would allow the interfering mutants to remain bound to, thereby sequestering RAS exchange
factors. The more severe interference phenotype of this novel interfering mutant suggests that it functions by
titrating out other positive regulators of RAS besides those encoded by ste6 and CDC25.
Mutant versions of RAS proteins are found in a wide variety
of human tumors (3). The normal vertebrate RAS regulates
cellular growth, morphology, and differentiation (4). In the
yeast Saccharomyces cerevisiae, RAS is required for vegetative
growth (5, 46). In the yeast Schizosaccharomyces pombe, RAS
is involved in pathways controlling sexual differentiation and
cellular morphology (19, 40, 41). In each of these diverged
species, it is evident that the nucleotide-bound state of RAS
proteins regulates its activity. The conversion of the inactive
RAS - GDP to the active RAS - GTP is regulated by guanine
nucleotide exchange factors (GEFs) structurally and function-
ally related to the yeast S. cerevisiae CDC25 gene product (13).
Previously, RAS mutants which dominantly interfere with
wild-type RAS functions in the yeast S. cerevisiae and in animal
cells, namely, H-rasA"al5 or its yeast homolog RAS2Aa-22 (48)
and H-rasA'"17 (15), have been identified. The H-rasAlal5 and
RAS2AIa-22 mutants likely act by titrating out upstream RAS
GEFs. Evidence for this comes from the observation that the
dominant interference of either mutant expressed in S. cerevi-
siae can be suppressed by overexpression of the RAS-GEF
encoded by CDC25 (45). Furthermore, in a two-hybrid assay,
yeast CDC25 was found to bind the RAS2Ala-22 mutant more
strongly than wild-type RAS2 (38). The mechanism by which
dominant interfering mutants titrate out GEFs remains un-
clear, but there is evidence to suggest that the interfering
mutants are locked into an inactive conformation that binds to
and sequesters the intracellular pool of GEFs (14, 28, 38).
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oratory, P.O. Box 100, Cold Spring Harbor, NY 11724. Phone: (516)
367-8376. Fax: (516) 367-8371.
t Present address: INSERM U-248, Faculte de Medecine Lariboi-
siere-Saint-Louis, 75010 Paris, France.
The goal of our current study was to probe the function of
RAS in the fission yeast S. pombe by generating dominant
interfering RAS mutants. The RAS pathways in S. pombe are
not mediated by adenylyl cyclase as they are in S. cerevisiae (5,
56). The organism S. pombe has a single RAS homolog, rasl
(19, 41), that is not involved in vegetative growth but rather is
required for sexual differentiation and cellular morphology
(40). A positive regulator of rasl, encoded by ste6 (26), is
structurally and functionally related to the S. cerevisiae RAS-
GEF encoded by CDC25. In S. pombe, two signals, nutrient
starvation and pheromones, lead to conjugation between the
two mating types h+ and h-. The conjugated cells then
sporulate to form zygotic asci. raslnuI cells are viable but
defective in sporulation and conjugation; such cells also are
rounded, whereas wild-type cells exhibit an elongated mor-
phology (20, 40). In contrast to raslnuI cells, ste6null cells are
defective in conjugation but are normal with respect to both
sporulation and cellular morphology. Disruption of the rasl
gene, therefore, has a more pronounced effect than disruption
of this upstream activator. The search for interfering mutants
of rasl in S. pombe is attractive since rasl is not an essential
gene and its protein product potentially regulates more than
one pathway, as suggested by its roles in both sexual differen-
tiation and cellular morphology. Here we describe the charac-
terization of a novel dominant interfering mutant of S. pombe
rasl containing substitutions at Asp-62. We have made analo-
gous mutants of S. cerevisiae RAS2 and vertebrate H-ras and
have characterized their interfering properties as well.
MATERIALS AND METHODS
Plasmids, yeast strains, and reagents. All strains and plas-
mids used in this study are described in Tables 1 and 2.
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TABLE 1. S. pombe and S. cerevisiae strains used in this study
Strain Relevant genotype Source or reference
S. pombe
SP66 h90 leul-32 ade6-216 David Beach
SP66-R1C22 h90 leul-32 ade6-216 ura4::adh-SPras CYsy22 This study
SP66-R1Y62 h90 leul-32 ade6-216 ura4::SPras1Tyr,62 This study
SP593 h90 leul-32 ade6-216 rasl::ras]VaI17 David Beach
SP870 h90 leul-32 ade6-210 ura4-D]8 David Beach
SPR2A h90 leul-32 ade6-216 ura4::RAS2Ma-22 59
SPRU h90 leul-32 ade6-210 ura4-D]8 rasl::ura4 59
S. cerevisiae
IR-1 MATa his3 leu2 ura3 trp] ade8 canl iral::HIS3 2
IR2.5 MATa his3 leu2 ura3 trpl ade8 canl ira2:ADE8 la
IR2.53 MATa his3 leu2 ura3 trp] ade8 canl iral::HIS3 ira2::ADE8 25
RB5 AMTh his3 leu2 ura3 trp] ade8 can] iral::HIS3 ira2::ADE8 cdc25::URA3 Roymarie Ballester
SPi MATa his3 leu2 ura3 trpl ade8 can] 56
STS1 MA4Ta his3 leu2 ura3 trp] ade8 can] rasl::URA3 ras2ts 48
TK161-R2V MATa his3 leu2 ura3 trpl ad8 can] RAS2Val-19 56
Plasmid pAAUN-rasl, expressing a cDNA for S. pombe rasi, SPraslTYr-62, respectively, were generated by transforming S.
was obtained from Hao-Peng Xu. Plasmid pART3-ste6, ex- pombe SP66 with a NotI fragment derived from plasmids
pressing the exchange factor for Rasl, and plasmid pUC-ral2, pVINCE1-SPraslC22 and pVIN1-SPraslY62 (see below), re-
containing the genomic clone of ral2, a putative upstream spectively. S. cerevisiae RB5 was constructed by mating a
regulator of Rasl in S. pombe (21), were the kind gifts of M. cdc25nuIl strain to an iralnull ira2null strain, sporulating, and
Yamamoto. Plasmid pART1-ral2, expressing the cDNA of the selecting for complementation of auxotrophic markers.
ral2 gene, was obtained by PCR using plasmid pUC-ral2 as the Construction of mutant S. pombe rasi library. Mutagenesis
template and two primers containing internal BamHI sites (in of S. pombe rasl was carried out by PCR as described by Zhou
boldface) to facilitate cloning into plasmid pART1: 5'-CT et al. (66). The following 5' and 3' oligonucleotide primers
TA1TAACGTCGGGATCCTAAACAGT-3' and 5'-GATA were used: 5'-C'TTIAGTGTGCTY1ATAGGATCCTGAA-3'
GAGCTACGGAGGATCCAAATGCA-3'. and 5'-GATCGGTGCATTCACCAAAGAGCTCA-3'. These
S. pombe SP66-R1C22 and SP66-R1Y62, containing the oligonucleotides contain, respectively, BamHIand SstI sites (in
integrated dominant interfering mutants SPraslCYs22 and boldface) for directional cloning into identical sites in the S.
TABLE 2. Vectors and plasmids used in this study
Plasmid Comments Reference or
source
S. pombe
pAISl byr2 expression 59
pART1-byrl byr] expression 59
pARTI ARS, LEU2, adh promoter 35
pART1-HRY57 H-rasTyr-57 expression This paper
pARTl-HRY57S186 H_rasTyr-57, Ser-186 expression This paper
pARTl-ral2 Upstream positive regulator of ras This paper
pART1-SPrasl S. pombe rasl expression Yan Wang
pART1-SPraslC22 S. pombe ras]Cys,22 expression This paper
pART1-SPraslN22 S. pombe raslAsn-22 expression This paper
pART1-SPraslG62 S. pombe rasl]lyA62 expression This paper
pART1-SPraslY62 S. pombe rasl]Ty,62 expression This paper
pARTl-ste6 S. pombe ras] nucleotide exchange factor 26
pVIN1 Vector for integration of genomic DNA This paper
pVINl-SPraslY62 S. pombe ras]Ty,r62 expression This paper
pVINCE1 Vector for integration and expression of cDNA This paper
pVINCE1-HR H-ras expression This paper
pVINCEl-HRA35 H_raSAla-35 expression This paper
pVINCEl-HRY57 H-rasTyr-57 expression This paper
pVINCE-HRA35Y57 H_raSAla-35, Tyr-57 expression This paper
pVINCEl-SPraslC22 S. pombe rasl Cys-62 expression This paper
pVINCE1-SPraslY62 S. pombe raslTyr-62 expression This paper
S. cerevisiae
pAD4A 2j,m, LEU2 2
pAD54 2,um, LEU2, Lerner epitope tagged 17
pAD4A-HRY57 H_rasTyr-57 expression This paper
pAD4A-R2A22 RAS2Ala-22 expression This paper
pAD4A-R2Y64 RAS2TYr-64 expression This paper
pAD54-R2Y64 Epitope-tagged RAS2TYr-64 expression This paper
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FIG. 1. Plasmids pVlNl and pVINCEI were constructed as de-
scribed in the text. All sites except for Xbal are unique in the
polylinker. These vectors contain the S. cerevisiae ADE2 gene, a
polylinker, or an S. pombe adh promoter flanked by S. pombe ura4
segments. The entire insert can be removed by Notl digestion for
transformation into S. pombe. Integration into the ura4 locus can be
verified by complementation of the adenine auxotrophy and loss of
uracil prototrophy.
pombe expression vector pART1 (35). A library of over 107
clones was generated from a pool of eight separate 50-,ul
PCRs.
Selection of S. pombe rasi dominant interfering mutants.
DNA from the mutant S. pombe rasl library was isolated and
transformed by the lithium acetate method (27) into wild-type
S. pombeSP870. Cells were plated such that approximately 200
to 300 transformants grew per selective plate. Colonies defec-
tive for conjugation or sporulation were detected by the iodine
vapor staining method (32). Plasmid DNA was isolated from
these cells and retransformed into wild-type cells to confirm
that the interference was due to the presence of the plasmid.
The mutations in S. pombe rasl were identified by Sanger
sequencing (49) of the full length of the gene.
Construction of pVINCEl and pVINl. pVINCE-1 (vector
for integration and cDNA expression; (Fig. 1) was designed to
facilitate integration of a cDNA expressed under adh promoter
control into the ura4 locus of S. pombe and was constructed as
follows. Plasmid pUCN was constructed from plasmid pUC1 18
by removing the polylinker with HindIll and EcoRI digestion,
blunt ending with Klenow polymerase, and ligating to NotI
linkers. The ura4+ gene was excised from vector pAIL (29) by
HindIlI digestion and treated with Klenow polymerase, and
NotI linkers were added for cloning into the vector pUCN,
generating plasmid pUC-ura4. An AscI restriction site was
introduced into the internal EcoRV site of ura4 by the use of
linkers. AscI linkers were then added onto a HindlIl-EcoRI
fragment obtained from pART1 (35) containing an adh pro-
moter with a polylinker. The fragment was cloned into the AscI
site of pUC-ura4, thereby disrupting the ura4 gene and gener-
ating plasmid pura4-adh. An SphlI site, just upstream of the adh
promoter, was converted into a Bcll site by linkers. An ADE2
gene was excised from plasmid pAZ11 (53) by restriction with
BglII and cloned directly into the Bcll site to generate
pVINCE-1. The ADE2 gene (53) of S. cerevisiae can comple-
ment the S. pombe ade6 auxotrophy (33, 42). After cloning of
the desired cDNA into the polylinker, the integrating fragment
can be excised by NotI digestion for transformation. Successful
disruption of the ura4 locus can be identified by growth in
adenine-free plates and failure to grow in uracil-free plates.
pVIN1 (vector for integration; Fig. 1) is similar to pVINCE1
except that it was designed for integration of cloned genomic
fragments. This plasmid was constructed by a partial BglII
digestion of pVINCE1 followed by PstI digestion to remove
the adh promoter, then blunt ended by T4 polymerase, and
self-religated.
The dominant interfering SPraslCys22 and SPraslTYr62 mu-
tants were cloned into pVINCE-1, using restriction enzyme
sites BamHI and SstI to create plasmids pVINCE1-SPraslC22
and pVINCE1-SPraslY62, respectively.
Site-specific mutagenesis of RAS genes and cloning into
expression vectors. Site-directed mutagenesis by the double-
primer method (12) was used to modify RAS genes (Trans-
former mutagenesis kit; Clontech, Palo Alto, Calif.). Primer
5'-TGGACAThTTGTATACGGCAGGGCAGGAAG-3' was
used to change residue 64 of S. cerevisiae RAS2, cloned into
plasmid YEplacll2 (23), from an aspartic acid to a tyrosine, to
create plasmid YEplacll2-R2Y64. Amino acid residue 57 of
human H-ras in plasmid pAAU-HR (59) was changed from an
aspartic acid to tyrosine, using the oligonucleotide 5'-CTGGC
CGGCGGTATACAGGATGTCCAA-3' to create plasmid
pAAU-HRY57. Position 35 of the effector loop (52, 64) in
wild-type H-ras (H-ras'W) and H-rasTYr-57 was changed from a
threonine to an alanine by mutagenesis of plasmids
pVINCE1-HR and pVINCE1-HRY57 by using the oligonucle-
otide 5'-ACGAATACGACCCCGCTATAGAGGATTC-3',
thereby creating plasmids pVINCE1-HRA35 and pVINCE1-
HRA35Y57, respectively.
Plasmid pAL-SPraslY62 contains the genomic rasl gene
with a Tyr-62 mutation and was constructed by exchanging a
BsaBI-SstI fragment of rasl from pART1-SPraslY62 into
plasmid pALR (59) containing a genomic clone of rasl. The
genomic clone of SPraslTYr,62 was then transferred into vector
pVIN1 to generate plasmid pVIN1-SPraslY62.
R4S2TY'` was amplified by PCR from plasmid YEplacll2-
R2Y64 by using two oligonucleotides, 5'-GAAAGGAGATATA
CAGAGTCGACAATGCCT-3' and 5'-GTGAAAATGGATGT
GAITTGTCGACTCTCICG-3', that contain intemal Sall sites (in
boldface) for insertion into yeast expression vectors pAD4A or
pAD54 (2, 17) to generate plasmids pAD4A-R2Y64 and pAD54-
R2Y64, respectively. Plasmid pAD4A-R2A22 was generated
similarly, using as the template the genomic clone of the RAS2""-77
allele (48). The HinsTyr mutant gene was excised as a BamHI-
SstI fragment from plasmid pAAU-HRY57 and cloned into vec-
tors pART1 and pVINCE1, to generate pART1-HRY57 and
pVINCE1-HRY57, respectively, or as a SalI-SstI fragment for clon-
ing into pAD4A to generate plasmid pAD4A-HRY57.
Cys-186 of the CAAX processing motif (62,63) of H-ras>57 was
changed to a serine by PCR-directed mutagenesis using oligonucle-
VOL. 14, 1994
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3710 JUNG ET AL.
otides 5'-CCTCAGGATCCGAATGACGGAATATAAGCT-3'
and 5'-CCATGGTCGACTCAGGAGAGCACACT(C1-3'. The
BamHI and Sal sites (in boldface) allowed for cloning into identical
sites in vector pARTl to create pART1-HRY57S186. The comple-
ment of ACT (underlined) encodes the serine mutation.
Conjugation and sporulation frequencies for S. pombe. After
cells were transformed, the colonies were grown and starved
for 1 week. Haploid cells of opposite mating types will conju-
gate to form zygotic asci that can be easily distinguished by
their boomerang morphology, the angle representing their
point of conjugation (see Fig. 2 and Results). In the case of
cells that are conjugation defective, diploids can be generated
by cell fusion. The sporulation of these diploidized cells
generates azygotic asci (see Fig. 2D). The frequencies of
zygotic or azygotic ascus formation, determined by microscopic
observation, were used to calculate, respectively, the conjuga-
tion and sporulation efficiencies.
Heat shock assays for S. cerevisiae. The heat shock assays
(50, 56) were performed by replica plating patches of cells that
had been starved for 2 to 3 days onto plates that were
preheated for 1 h at 52 or 55°C, incubated for 2.5, 5, and 10
min at the indicated temperature, and then transferred to 30°C
for 2 to 3 days.
Two-hybrid system for studies of RAS interactions. We used the
modified two-hybrid system developed by S. M. Hollenberg, H. R.
Stemglanz, and H. Weintraub as described by Vojtek et al. (58) to
analyze interactions of RAS with its effectors. Reporter S. cerevisiae
strain LAO0 and plasmids pLexA-Rasyr, pLexA-Rasvl2, pLexA_
RaSA15, pVPl6, pVPl6-CYR, and pVPl6-RAF were the generous
gifts of Anne Vojtek. The gene encoding H-rasTYS7 was amplified
by PCR using the two oligonucleotides 5'-CCTCAGGATCCGA
ATGACGGAATATAAGCT-3' and 5'-CCATGGTCGACTCAG
GAGAGCACACAC1T-3'. These oligonucleotides contain intemal
BamHI and Sail sites (in boldface), respectively, to permit cloning
into vector pBTM116 (58), creating pLexA-HRY57.
Purification of H-ras proteins and guanine nucleotide bind-
ing. H-ras' and dominant interfering H-rasTYr-57 were cloned
into the pTrcHis Xpress System (Invitrogen, San Diego, Calif.)
vectors for expression of His6-tagged proteins and transformed
into Escherichia coli DH1OB (Bethesda Research Laborato-
ries, Gaithersburg, Md.). Protein was purified as described by
the manufacturers except that 1 mM MgCl2 was included in all
buffer conditions. The supernatant was passed through Ni2+-
charged Sepharose ProBond resin (Invitrogen) and eluted by
using step gradients of lysis buffer containing 40, 60, 100, 200,
500, and 1,000 mM imidazole. The H-ras proteins eluted at 200
mM imidazole at greater than 90% purity, as judged by sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE) analysis. The proteins were concentrated by Centricon
(Amicon, Lexington, Mass.) centrifugation, adjusted to 40%
glycerol, and stored at -20°C. Nucleotide-free H-ras proteins
were prepared essentially as described by Crechet et al. (11)
except that after EDTA treatment, buffer was exchanged by
Centricon centrifugation.
Relative affinities for nucleotides were determined as de-
scribed by Farnsworth and Feig (14) by incubating 5 pmol of
purified nucleotide-free H-ras proteins in 100 pI of binding
buffer containing 0.5 ,uM [3H]GDP and various concentrations
of unlabeled GDP or GTP as described for Fig. 5. Bound
counts were determined by a nitrocellulose filter assay (16).
Interaction of H-ras proteins with the catalytic domain of
the human cdc25GEF. A plasmid designed to expressed gluta-
thione S-transferase (GST) fused to a human RAS guanine
nucleotide exchange factor, cdc25GEF (60), was made by
cloning of codons 863 to 1275 of cdc25GEF into vector
pGEX-2T (Pharmacia, Piscataway, N.J.). Induction and bind-
ing of the GST-cdc25GEF to glutathione-agarose were per-
formed as described previously (31). Plasmids for expression of
His6-tagged H-rasWT and H-rasTYr-57 proteins are described
above. The H-rasAsni17 expression plasmid, pAT-rasH(17N),
was kindly provided by C. Der. E. coli cells containing each of
the H-ras expression plasmids were grown to an optical density
at 600 nm of 0.4. Isopropylthiogalactopyranoside (IPTG) was
added to a final concentration of 1 mM, and the cultures were
incubated overnight at 28°C. Triton X-100-solubilized extracts
were prepared as described previously (31).
To examine the interaction of the H-ras proteins with the
catalytic domain of cdc25GEF, suspensions of glutathione-
agarose beads complexed to 30 ,ug of GST-cdc25GEF were
incubated at 4°C while rotating with 1 ml of a phosphate-
buffered saline (PBS; 138 mM NaCl, 2.7 mM KCl, 10 mM
Na2HPO4, 1.8 mM KH2PO4 [pH 7.4]) solution containing 0.5
mM EDTA (to ensure that H-ras proteins remain nucleotide
free), 1% Triton X-100, and a final 0.5-pLg/ml concentration of
H-rasWT, H-rasAsn-l7, or H-rasTyr-57 protein. After 2-h incuba-
tions, each of the suspensions was divided equally into three
tubes and then pelleted and washed three times with 1 ml of
PBS containing 1% Triton X-100 without EDTA. Proteins
bound to the glutathione-agarose were eluted from one set of
triplicate pellets by addition of 25 [lI of 5 mM glutathione, after
which the samples were incubated at 22°C for 1 h and
overnight at 4°C (sample 1 in Fig. 6). To the other two samples
were added 25 [lI of PBS containing 10 mM MgCl2 and either
10 mM GTP (sample 2 in Fig. 6) or 10 mM GDP (sample 3 in
Fig. 6), after which the samples were incubated at 22°C for 1 h
and overnight at 4°C. After removal of the material eluted by
conditions used for samples 2 and 3, the H-ras protein
remaining bound to the glutathione-agarose-GST-cdc25GEF
matrix was released by treatment with 25 RI of 5 mM glutathi-
one for 1 h at 22°C and overnight at 4°C (samples 4 and 5,
respectively). Samples were analyzed by Western blot (immu-
noblot) analysis, using the Immunolite assay kit (Bio-Rad,
Richmond, Calif.) and anti-RAS antibody A6-1 (Oncogene
Sciences, Uniondale, N.Y.) as the primary antibody.
Binding of guanine nucleotides to preformed complexes of
H-ras proteins and the catalytic domain of human cdc25GEF.
H-raswT, H-rasAsn-l7, and H-rasTYr-57 proteins were bound to
glutathione-agarose-GST-cdc25GEF as described above. The
final pellets were resuspended in PBS without EDTA. Aliquots
of these suspensions, containing equivalent amounts of H-
rasWT, H-rasAsnl7, and H-rasTyr-57, as judged by SDS-PAGE
and Coomassie blue staining, were incubated with 1 ,uM
[3H]GDP or [3H]GTP (10 Ci/mmol; New England Nuclear) in
the presence of 5 mM MgCl2 for 30 min at 22°C and then 5 min
at 0°C. The entire reaction mixture was passed through a
nitrocellulose filter as described previously (5) to determine
the 3H-labeled guanine nucleotides bound to H-ras proteins.
The bound counts therefore reflect the guanine nucleotides
bound to H-ras proteins both complexed to and dissociated
from GST-cdc25GEF. At 1 ,uM guanine nucleotide, there was
no detectable dissociation of either H-rasAsn-l7 or H-rasTYr-57
protein from the complex with GST-cdc25GEF, whereas H-
rasWT protein was dissociated from GST-cdc25GEF to near
completion (data not shown). In control reactions containing
glutathione-agarose-GST-cdc25GEF, less than 40 cpm of 3H-
labeled guanine nucleotides was found to bind.
RESULTS
Isolation of dominant interfering S. pombe rasi mutants.
Upon starvation and stimulation by pheromones, S. pombe
cells of opposite mating types will conjugate and then undergo
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FIG. 2. Suppression of sexual and morphological development by interfering mutants of S. pombe rasl. The dominant interfering mutant
SPraslCys22 (B and E) or SPraslTyr57 (C and F) was expressed in either haploid (A to C) or diploidized (D to F) wild-type S. pombe SP870.
Wild-type cells, transformed with the control vector pART1, normally exhibit an elongated morphology (n; panel A). Wild-type haploid cells, under
starvation conditions, will conjugate and then sporulate to form zygotic asci (za [A]), whereas diploid cells will sporulate to form azygotic asci (aa
[D]). Wild-type cells expressing the SPraslCQs-22 interfering mutant are defective in conjugation (B) but not sporulation (E). Wild-type cells
expressing the SPraslTYr,57 interfering mutant are defective in conjugation (C) and sporulation (F). Furthermore, cells containing SPrasJTyr-57 are
morphologically defective. They are rounded (r) instead of elongated (n).
sporulation and ascus formation (Fig. 2A). Carbohydrate
accumulation is a hallmark of the sporulation process and can
be detected by staining with iodine vapor (32). Since S. pombe
rasl regulates conjugation and sporulation, cells with a defect
in the rasl pathway will not stain with iodine. Cells containing
a hyperactivated rasl are also defective in conjugation and will
not stain with iodine (40). The iodine staining method was
therefore used to isolate mutants of S. pombe rasl that can
block the conjugation-sporulation process. An expression li-
brary for mutants of rasl was generated by PCR as described
in Materials and Methods. Of 26,000 colonies established by
transformation of wild-type S. pombe with the library, 69 failed
to stain positively for starch accumulation by iodine vapor. Of
the 69, 45 were determined microscopically to have a pheno-
type indistinguishable from that induced by activated rasl
mutants. S. pombe cells containing an activated rasl allele
exhibit an exaggerated sexual response characterized by
heightened agglutination, the formation of elongated conjuga-
tion tubes, and a failure to conjugate under starvation condi-
tions (20, 40). These characteristics are referred to as a
hypersexed phenotype. Plasmid DNA was successfully rescued
from 21 of the remaining 24 isolates. Of these, 13 were wild
type on retransformation and 8 dominantly interfered with
conjugation or sporulation. These eight interfering mutants
were equally distributed into two phenotypically distinct cate-
gories. The first type of interfering mutants conferred a ste6null
phenotype onto wild-type S. pombe cells (Fig. 2B and E). ste6
encodes the S. pombe homolog of S. cerevisiae RAS-GEF,
pARTI
SP870
SP870
diploid
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TABLE 3. Effects of interfering mutants on various strains
Strain FrequencY`'
(relevant genotype) Expressed gene' Morphology CnuainpratoConjugation Sporulation''
SP1 (wild type) Elongated + + + + + + + +
SpraslCys-22 Elongated - + + + +
spraslAsn-22 Elongated - + + + +
RAS2Ala-22 Elongated - + + + +
SPrasJ0ly-62 Rounded --/
SPrasJTyr-62 Rounded +
H_rasAla-35d Elongated + + + + + + + +
H-rasTyr-57 Rounded
-/+
H_rasAla-35 Tyr-57td Rounded
-/+
H-rasTyr-s57, Ser-186 Elongated ++++ ++++
SP593 (rasJVaIl7) Hypersexede - ++++
RAS2AI1-22 Hypersexed - ++++
SprasICys-22 Hypersexed - + + + +
SPraSJTyr-62 Hypersexed - + + + +
SPRU (raslnull) Rounded
-/
SPraSlTyr-62 Rounded
- +
a Genes were expressed from the vector pARTI unless otherwise specified. - indicates control vector.
"Relative to the wild-type frequency. Each + designates an increment of 25%; -/+ indicates less than 1%.
For conjugation-defective cells, polyethylene glycol fusion was used to generate diploids for analysis of sporulation efficiencies.
" Expressed from the vector pVINCEI.
' Refers to the elongated conjugation tubes seen in strains expressing hyperactivated rasl.
CDC25, and its disruption manifests as a conjugation defect
(26). The second type of interfering mutants conferred a
rasJnuil phenotype when transformed into wild-type cells (Fig.
2C and F). Similar to the first type of interfering mutants,
wild-type cells transformed with the second type of mutants
were also conjugation defective. However, unlike the first type
of mutants, they caused additional defects: cells were rounded
rather than elongated, and sporulation of diploid cells was also
suppressed. Sequence analysis of the mutant rasi genes re-
vealed that only four of the eight clones had single missense
mutations. Each of the ste6null or raslnul category of interfer-
ing mutants had two members.
There was a correlation between the positions of the muta-
tions and the interfering phenotypes that they induced (Fig. 2).
The two mutants that conferred a phenotype similar to a ste6
disruption were altered at amino acid 22, where a serine
encoded by AGT was changed into a cysteine (TGT, transver-
sion, SPraslCYs-22) or into an asparagine (AAT, transition,
SPraslAsn-22). These are analogous to the Asn-17 mutation of
vertebrate H-ras (15). Those interfering mutants that con-
ferred a phenotype similar to a rasi disruption were altered at
amino acid position 62, where an aspartic acid encoded by
GAC was changed to a glycine (GGC, transition, SPras161y-62)
or to a tyrosine (TAC, transversion, SPraslTYr-62). Others have
previously introduced mutations into the analogous Asp-57 of
H-ras, but interfering mutants were not created thereby (14,
28).
Genetic analysis of the S. pombe interfering mutants. We
observed that neither the SPraslCYs-22 nor the SPraslTYr-62
mutant blocked the hypersexed phenotype associated with an
activated raslva,l7 (Table 3), thereby indicating that they both
interfere upstream of rasi. Position 22 of S. pombe rasl
corresponds to position 17 of vertebrate H-ras. Mutations at
position 17 of vertebrate H-ras have been shown to dominantly
interfere with RAS function in vertebrates (14, 15). A similar
mutation at nearby position 15 of H-ras, or the analogous
position 22 of S. cerevisiae RAS2, also creates a dominant
interfering mutant that likely functions by sequestration of the
RAS-GEF in S. cerevisiae encoded by CDC25 (38, 48). In S.
pombe, the interfering property of SPraslCys-22 is indistinguish-
able from that observed for RAS2Ala-22 (Table 4). We there-
fore predicted that the SPraslCYss22 mutant might interfere
with Rasl by similarly sequestering the S. pombe homolog of
the CDC25 gene product encoded by ste6. Indeed, overexpres-
sion of ste6 in a wild-type strain containing either the dominant
interfering SPraslCys-22 or RAS2Ala-22 mutant suppressed the
conjugation defect (Table 4). The conjugation defect can also
be overcomed by overexpression of ras] or the kinase that
functions downstream of rasi, byri (39), or byr2 (59). Our
genetic data therefore suggest that mutants represented by
positions 15 and 17 of H-ras have as their common target the
CDC25 class of regulatory exchange factors.
In contrast to SPraslCYs22, which blocked only conjugation,
the SPraslTYr-62 interfering mutant blocked conjugation and
sporulation and interfered with cellular morphology. Overex-
pression of the protein kinase encoded by byri or byr2 in a
TABLE 4. Suppression of interference by various genes"
Expressed FrequencyStrain gee Morphologygene Conjugation Sporulation
SPR2A Elongated - + + + +
byrl Elongated +++ ++++
byr2 Elongated +±+ ++++
rasI Elongated +±+±+ ++++
ste6 Elongated +++ ++++
SP66-R1C22 - Elongated - + + + +
byri Elongated +++ ++++
byr2 Elongated +++ ++++
rasI Elongated +++ ++++
ste6 Elongated +++ ++++
ral2 Elongated - + ++ +
SP66-R I Y62 Rounded - -/+
byri Rounded - +++
byr2 Rounded - +++
rasI Elongated +++ +++
ste6 Rounded - -/+
ral2 Rounded - -/+
" For details, see the footnotes to Table 3.
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Strain
ra2
RAS2VC19!
Control 55°C/2.5 min. Plasmid
AD54
AD4LR2Y64
AD54R2Y64
AD54
AD4AR2Y64
AD54R2Y64
FIG. 3. Suppression of heat shock phenotype in S. cerevisiae con-
taining hyperactivated RAS2. RAS is hyperactivated in these strains
either because of disruption of the GTPase-activating protein encoded
by IRA2 (strain IR2.5) or because of the presence of the activated
allele RAS2VaI-,9 (strain TK161-R2V). Plasmids pAD4A and pAD54
are high-copy-number plasmids for expressing genes from an adh
promoter (see Table 2).
SPraslTYr-62-containing strain was only able to suppress the
sporulation defect, whereas overexpression of wild-type rasl
was able to overcome all SPraslTYr-62_induced defects (Table
4). This suppression profile is indistinguishable from that
observed for a strain with rasl deleted (39, 59). The ability of
the SPraslTYr-62 mutant to block Rasl function more pro-
foundly than the SPraslPys-22 mutant suggests that Rasl is
regulated by other activators besides that encoded by ste6. ral2
has been proposed to encode an alternate positive regulator of
rasl, since it functions upstream of rasl and its disruption is
phenotypically indistinguishable from a rasl disruption (22).
We observed that ral2 overexpression did not rescue interfer-
ence by SPraslCys-22 or SPraslTYr-62 (Table 4).
Genetic analysis of S. cerevisiae R4S2TY'-64. In S. cerevisiae,
products of RAS genes are involved in cell growth and regu-
lation of cellular responses to nutrient signals. They are
regulated in a positive fashion by the gene product of CDC25
(6, 8), encoding its GEF, and negatively by products of IRA]
and IRA2, encoding homologs of mammalian GTPase-activat-
ing proteins (55). S. cerevisiae cells containing a hyperactivated
RAS exhibit a characteristic heat shock sensitivity (47).
A mutant analogous to SPraslTYr-62, RAS2Tyr-64 was made
from RAS2 of S. cerevisiae to determine if it too has interfering
properties. We found that RAS2Tyr-64 inhibits growth of S.
cerevisiae cells and that this inhibition can be relieved by
overexpression of elements in the RAS-adenylyl cyclase path-
way. RAS2TYr-64 did not inhibit the growth of a strain contain-
ing an activated RAS2Va-19 allele, therefore showing that
RAS2TYr-64, like SPraslTYr-62 in S. pombe, functions upstream
of RAS (data not shown). As further indication that the
interference is upstream of RAS, RAS2TY` cannot attenuate
the heat shock sensitivity of a RAS2Vall9-containing strain
(Fig. 3; Table 5).
We next tested if RAS2TYr-64 can attenuate the heat shock
sensitivity resulting from RAS that is hyperactivated by disrup-
tion of the negative regulators encoded by IRAI and IRA2.
RAS2TYr-64 was able to attenuate the heat shock sensitivity of
strains deleted of either or both IRAI and IRA2 (Fig. 3; Table
5). An iralnull ira2fnull strain is still heat shock sensitive when
the positive regulator CDC25 is also deleted (1). RAS2TYr-6
was capable of reversing the heat shock phenotype even in a
cdc25null iral null ira2nuIl strain (Table 5). In contrast, we found
that the interfering mutant RAS2Ala-22 can attenuate the heat
shock phenotype of an iralnull ira2null strain but not a cdc25null
iralnuln ira2null strain. We take this to mean that a positive
TABLE 5. Relative suppression of heat shock phenotype
Suppression of heat shock sensitivity"
Relevant genotype RASa22 RAS2Tyr-64
_raSTyr-57RA2l-2RAS2 T-6 H-aT
iraInull + + +
ira2null + + +
iralnull ira2null + +
cdc25null iralnull ira2nuIl +
RAAs2Val-19
a +, attenuation of the heat shock sensitivity relative to the same strain
containing a control plasmid; -, absence of effect on heat shock sensitivity. The
vector used in the control and for expression of the interfering RAS mutants,
resulted in no suppression of heat shock sensitivity.
b Heat shock assays were carried out at 55°C (iralnulI and ira2nuIl) or at 52°C
(iralnull ira2null, cdc25null iralnuIl ira2null, and RAS2Val-s9, because of the in-
creased heat shock sensitivity of the strains).
regulator of RAS2 other than CDC25 exists in S. cerevisiae and
is also the target of RAS2TYr-I .
Interfering properties of mammalian H-ras rS7. A muta-
tion analogous to SPraslTYr-62 was made in H-ras at position
57, H-rasTyr57, and expressed in wild-type S. pombe or S.
cerevisiae cells. The interference resulting from SPraslTYr-62
was mimicked by H-rasTYr-57 when expressed in S. pombe
(Table 3). However, in S. cerevisiae, it interfered more weakly,
failing to suppress the heat shock phenotype of strains deleted
of both IRAI and IRA2 (Table 5).
We also studied two double mutants of H-ras in S. pombe.
To test if the interfering mutant was functioning via titration of
upstream regulators rather than downstream effectors, we
constructed a double mutant that contains both a Tyr-57
mutation and an effector loop mutation, Ala-35, that is be-
lieved to block downstream signaling from ras (52). This
double mutant, H-rasAIa-35, Tyr-57 , still induced a raslnuII phe-
notype, indicating that the dominant interference is not due to
blocking downstream elements of the rasl pathway (Table 3).
The H-rasla-35 mutant did not exhibit any interfering func-
tions, which is consistent with observations by others that
Thr-35 substitutions of H-ras block its own function without
interfering with endogenous H-ras functions (14, 28). We also
tested if membrane localization is required for the dominant
interfering properties of H-rasTyr 7. It was previously shown
that blocking the posttranslational addition of lipid to Cys-186
of the CAAX motif (63) for the interfering mutant H-rasAsnl7
abolished its interfering properties (15). Mutation of Cys-186
to an arginine in H-ras r-57 also blocked its interfering activ-
ities when tested in S. pombe. H-rasTyr-s7, Arg-186 failed to
inhibit sexual development or effect the cellular morphology of
wild-type S. pombe cells (Table 3).
Two-hybrid analyses of interactions between H-ras proteins
and its effectors. The two-hybrid system (18) has been used to
study proteins that interact with H-ras (57, 58). The S. cerevi-
siae reporter strain L40 permits the detection of protein-
protein interaction by transcriptional activation of both a HIS3
and a lacZ gene. As reported previously (58), both H-ras'W
and activated H-rasval2 interacted with the catalytic domain
of S. cerevisiae exchange factor CDC25, indicated by comple-
mentation of host histidine auxotrophy and by a ,B-galactosi-
dase color assay (Fig. 4). They also interacted with two
downstream effectors of RAS, budding yeast adenylyl cyclase
and mammalian RAF (Fig. 4). In contrast, both the H-rasMals5
and H-rasTYr-57 interfering mutants failed to interact with the
downstream effectors. Relative to H-ras'W, the H-rasAaI1s and
H-rasTyr-57 mutants interacted more strongly with CDC25, as
indicated by the increased intensity from the ,-galactosidase
VOL. 14, 1994
 o
n
 April 12, 2012 by M
AIN LIBRARY
http://m
cb.asm
.org/
D
ow
nloaded from
 
3714 JUNG ET AL.
VPI6 fusions
LO)
cmJ
0 ClE U
) ) cr
F H-ras
LexA H-rasVaI 12
fusions H-rosAla 15
L H-rcsTYr57
A: His+ plate B: His plote C: ,B-golactosidase assay
FIG. 4. Two-hybrid analysis of H-ras and mutant interactions with effectors. The reporter strain used in this system permits for detection of
protein-protein interaction through transcriptional activation of both the HIS3 and the lacZ gene. Cells were transformed with the plasmids noted
in panel A. (A) Growth of transformants on histidine-containing plates. (B) Growth of transformants on histidine-free plates. (C) Growth of cells
on histidine-containing plates followed by assay for P-galactosidase activity.
assay (Fig. 4). This finding confirms our genetic data suggesting
that the interfering mutants function through sequestration of
upstream activators of RAS.
Guanine nucleotide binding characteristics of H-rasTyr57.
Previously characterized dominant interfering mutants of RAS
have been shown to have altered affinities for guanine nucle-
otides, exhibiting a preference for binding GDP over GTP (14,
28, 45). We therefore determined if this was a property shared
by the H-rasT'yr-57 mutant. H-raswT and H-rasTyr-57 were
purified as fusion proteins, and their nucleotide binding prop-
erties were determined by using a relative affinity assay as
described by Farnsworth and Feig (14) (Fig. 5). Whereas
H-ras'W bound GDP and GTP with similar affinities, the
H-rasTYr-57 mutant exhibited less than a 10-fold preference for
GDP in the presence of GTP. Therefore, H-rasTYr-57, similar to
other interfering mutants, binds preferably to GDP over GTP.
Interaction of H-ras proteins with the catalytic domain of
the human cdc25GEF. We next determined if there were
1 00
C 80
0
.0
c)
C60
E$ 40
a-
I 20
010
0
0 5 10 15 20 25 30 35 40
[GDP or GTP]/[[3H]GDP]
FIG. 5. Relative affinities of H-ras (A) and H-rasTYr-57 (0) for
GDP ( ) and GTP (- -) were determined as described in
Materials and Methods. A constant 0.5 mM [3H]GDP was used in the
presence of various concentrations of unlabeled GDP or GTP. The
abscissa represents the concentration of unlabeled nucleotide used
divided by the fixed concentration of labeled [3H]GDP. Percentages of
bound counts were determined from the ratio of bound counts
attained in the presence of unlabeled nucleotide over that obtained
without unlabeled nucleotides added. Results are averages of duplicate
datum points which differed by no more than 20%.
biochemical differences between the interactions of wild-type
or interfering mutant H-ras proteins and a human homolog of
S. cerevisiae CDC25, cdc25GF. A GST fusion with the catalytic
domain of cdc25GEF was constructed as described in Materials
and Methods. Wild-type or mutant H-ras protein, in the
nucleotide-free state, readily associates with GST-cdc25GEF
bound to glutathione agarose (Fig. 6, lane 1), confirming
previous observations by Lai et al. (31). The H-ras'W protein
could be readily released from the glutathione agarose-GST-
cdc25GEF complex by addition of 10 mM GTP or GDP (Fig. 6).
The H-raSAsn1 mutant could be only partially released from
the agarose matrix by addition of 10 mM GTP or GDP.
However, in marked contrast to H-ras'W and H-rasAn17
proteins, 10 mM GTP or GDP allowed only a trace release of
H-rasTyr-57 protein (Fig. 6, lanes 2 and 3, respectively). Follow-
ing elution of the H-ras proteins by GTP or GDP from the
complexes, we treated each of the resulting complexes with 5
mM glutathione to determine the amounts of the various H-ras
proteins remaining bound to GST-cdc25GEF. Western blot
1 2 3 4
Asn17 _A_
1 2 3 4 5
wt ....
FIG. 6. Guanine nucleotide-dependent release of H-ras proteins
from a complex with GST-cdc25GEF. H-ras proteins were bound to
glutathione-agarose-GST-cdc25GEF and divided into three equivalent
portions. For each portion, H-ras proteins were released by 5 mM
glutathione (lane 1), 10 mM GTP and 10 mM MgCl2 (lane 2), or 10
mM GDP and 10mM MgCl2 (lane 3). After elution with GTP or GDP,
the remaining H-ras proteins bound to the glutathione-agarose-GST-
cdc25GEF were eluted with 5 mM glutathione (lanes 4 and 5, respec-
tively). The relative amounts of H-ras proteins eluted by these various
conditions were determined by Western analysis as described in
Materials and Methods.
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TABLE 6. Binding of guanine nucleotides to RAS * GST-
cdc25GEF complexes
cpm of nucleotide bound
Protein
GDP GTP
H-rasw' 670 678
H-rasAsn-l7 628 526
H-rasTyr-57 633 709
a 3H-labeled guanine nucleotide binding to matrices containing GST-
cdc25GEF bound to the indicated H-ras protein was monitored in a nitrocellulose
filter binding assay as described in Materials and Methods. Samples containing
equivalent amounts of H-ras proteins were incubated with 1 FM [3H]GDP or
[3H]GTP as indicated at 22°C for 30 min. Values are averages of duplicate datum
points which did not differ by more than 15%. Less than 40 cpm of [3H]GDP or
[3H]GTP was found to bind in negative control reactions containing glutathione-
agarose bound only to GST-cdc25GEF. Similar results were obtained in two
independent experiments.
analysis of these glutathione-released samples indicated that
only trace amounts of H-ras'W remained bound to the matrix,
whereas significant amounts of H-rasTyr-57 and H-rasAsn17
proteins remained bound after GDP or GTP treatment. The
defect in the ability of guanine nucleotides to release H-
rasAsn-17 or H-rasTYr-57 from cdc25GEF might explain how
interfering mutants sequester endogenous pools of GEF to
block normal RAS functions. The more severe defect apparent
in H-rasTyr-57 might explain why it is a stronger interfering
mutant than H-rasnl1
Binding of guanine nucleotides to preformed complexes of
H-ras proteins and the catalytic domain of human cdc25GEF.
GDP and GTP are unable to effectively disrupt a complex of
nucleotide-free H-rasTYr-57 and GST-cdc25GEF under condi-
tions in which H-ras'W is readily dissociated from GST-
cdc25GEF. This observation indicates that either the H-rasTYr-57
mutant, when complexed with GST-cdc25GEF, has a very low
affinity for guanine nucleotides and hence remains in a nucle-
otide-free state tightly complexed with GST-cdc25GEF or that
the binding of guanine nucleotides to the H-rasTYr-57 . GST-
cdc25GEF complex does not induce the conformational
changes in H-rasTYr-57 necessary for its release from GST-
cdc25GEF. We therefore examined the ability of complexes of
GST-cdc25GEF and either H-ras"', H-rasAsnl7, or H-rasTyr-57
protein to bind 3H-labeled guanine nucleotides at a concen-
tration of 1 p.M. Previous work has shown that a GDP or GTP
concentration of 1 p,M is above that required for saturation of
binding of the H-ras * GST-CDC25GE complex (37). At this
concentration of guanine nucleotides, H-ras r protein is
released to near completion (data not shown; see reference
37), whereas mutant H-ras proteins remain bound to GST-
cdc25GEF. Therefore, we determined the total guanine nucle-
otide bound to H-ras proteins both complexed to and dissoci-
ated from GST-cdc259EF* There was no significant change in
the ability of H-ras'r, H-rasAsn-17, or H-rasTYr-57 protein, as a
preformed complex with GST-cdc25GEF, to bind guanine
nucleotides (Table 6). Thus, in this assay, H-rasln-l7 or
H-rasTYr-57 protein complexed to GST-cdc25GEF does not have
any apparent defect in the ability to bind guanine nucleotides.
Rather, the binding of guanine nucleotides to these complexes
does not allow the H-rasln-l7 or H-rasTYr-57 protein to disso-
ciate from cdc25GEF.
DISCUSSION
Dominant interfering mutants of rasl that block rasl func-
tions when expressed in wild-type S. pombe cells have been
isolated. These mutants fall into two categories. Type I confers
a ste6null phenotype. Type II confers a raslnul phenotype. Type
I mutants, analogous to the previously described H-rasAlal5
(48) and H-rasMal17 mutants (15), likely function by titrating
out some positive regulators of RAS, e.g., the nucleotide
exchange factors encoded by the S. pombe ste6 gene and the S.
cerevisiae CDC25 gene. Evidence for this comes from our
observation that the interfering phenotypes induced by the
SPraslQlys22 mutant or the RAS2Ma-22 mutant can be com-
pletely reversed by overexpression of ste6. In a two-hybrid
protein-protein interaction experiment, the type I human
H-rasAla 15 mutant binds the yeast S. cerevisiae exchange factor,
CDC25, more strongly than H-ras"'. We also demonstrate
that the H-rasni'7 protein binds more stably to the catalytic
domain of human cdc25 gene product, cdc25GEF, at concen-
trations of guanine nucleotides that will effectively dissociate
H-ras'W from a similar complex.
The type II mutants, like the type I mutants, also function
upstream of RAS and not by titrating out downstream effectors
of RAS. First, SPraslTYr,62 did not diminish the hypersexed
phenotype of S. pombe cells containing activated Raslval'l7,
and RAS2TYr-64 did not block the heat shock phenotype in
S. cerevisiae cells containing activated RAS2Vall9. These ob-
servations also indicate that it is unlikely that these mu-
tants interfere with RAS processing, as the mechanism for
interference. Second, we also constructed a double mutant,AIa-35, Tyr-57H-ras , containing an Ala-35 mutation that reduces
biological activity of H-ras by disrupting interaction with the
immediate downstream target (52). The double mutant main-
tained its ability to block rasl function. Third, in a two-hybrid
study, it was found that the H-rasTYr-57 mutant was not able to
interact with two downstream effectors, adenylyl cyclase and
RAF, but bound CDC25 more strongly. Both the double-
mutant experiment and the results from the two-hybrid system
support the conclusion that the H-rasTyr-57 mutant is interfer-
ing by titrating out upstream activators of RAS.
The type II mutants represent a novel class of interfering
mutants with properties distinguishing them from the type I
mutants. They exhibit an interference more pronounced than
that observed for the type I mutants. Type II mutants can
inhibit all rasl-associated phenotypes in S. pombe, whereas
type I mutants, similar to a ste6 disruption, can block conjuga-
tion but cannot interfere with sporulation or cell morphology.
The type I interfering mutants can be overcome by overexpres-
sion of ste6, suggesting that ste6 is its target. Interference by
type II mutants cannot be overcomed by overexpression of
ste6. In S. cerevisiae, a type II mutant can attenuate the heat
shock sensitivity of an iralnull ira2null or a cdc25null iralnull
ira2null strain. In contrast, a type I mutant attenuated the heat
shock sensitivity of an iralnull ira2null strain but not a cdc25null
iralnull ira2null strain. The type II mutant is also biochemically
distinguishable from the type I mutant in a cdc25GEF binding
and release assay. We showed that a complex of H-ras'T, in its
nucleotide-free state, and cdc25GEF can be readily disrupted in
the presence of guanine nucleotides. Under identical condi-
tions, a complex containing H-ras fry57 is more severely im-
paired in the ability to dissociate from cdc25GEF than is a
similar complex containing H-rasAsnl7. The more severe de-
fect in dissociation for type II mutants may explain why it
interferes more strongly than type I mutants. The more severe
defect, however, does not explain the genetic data indicating
that the type II mutants interfere more profoundly with RAS
functions than do the type I mutants and that they do so even
in the absence of the known GEFs. This suggests that type I
and type II interfering mutants have different specificities, with
the type II mutants targeting other activators of RAS besides
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those encoded by ste6 in S. pombe and its homolog CDC25 in
S. cerevisiae.
The type II mutants have amino acid substitutions at a site
previously undescribed for a RAS dominant interfering mu-
tant, namely, that corresponding to position 57 of human
H-ras. Asp-57 of H-ras localizes to a DX2G motif that is strictly
conserved not only for the RAS superfamily but also for the
GTPase superfamily (4). This indicates a structural and func-
tional conservation of this region in this class of proteins.
Ser-17, Thr-35, and Asp-57 of H-ras represent three amino
acids critical for Mg2+ interaction (36, 43, 44). The importance
of Mg2+ coordination in H-ras regulation is emphasized by the
fact that appropriate alterations of either Ser-17 or Asp-57 can
generate dominant interfering mutants. Previous reports have
suggested that the deliberate manipulation of position 57
might generate interfering mutants of H-ras. Neither an Ala-57
(28) nor an Asn-57 (14) mutation proved interfering, thus
indicating that the generation of interfering mutants at this
position is dependent on the amino acid substitution.
The mechanism of interference is not fully understood. It
has been shown that the nucleotide-free or GDP-bound form
of RAS complexes more tightly to GEFs than the GTP bound
form of RAS (31). Defects in the ability of RAS to bind
guanine nucleotides might therefore explain how interfering
mutants function. We have shown here that whereas wild-type
H-ras binds GDP and GTP with similar affinities, a type II
interfering mutant binds guanine nucleotides, but with a
preference for GDP over GTP. This is a property shared by
type I interfering mutants (14, 15, 28). Such a bias, however, is
insufficient for predicting whether a RAS mutant will be
interfering, since an Ala-57 mutation (28) was not interfering
although it exhibited a 39-fold bias for GDP over GTP. A
defect in nucleotide binding to RAS proteins also cannot
account for dominant interference properties, since activated
mutants of H-ras that exhibit profound defects in nucleotide
binding have been described (16, 30). From the work presented
here, showing that the mutants are impaired in the ability to be
dissociated from cdc25GEF by guanine nucleotides, and the
work of others (14, 28), we suggest that a common defect of
dominant interfering mutants in RAS proteins may be the
inability to adopt a guanine nucleotide-bound conformation
necessary for release from cdc25GEF-related molecules.
The discovery of type II interfering mutants opens new
opportunities for further investigations. First, the high-affinity
interaction between the type II mutants and GEFs might serve
as a biochemical tool for purification and characterization of
these alternate activators. These other activators of RAS might
also be found by screening for suppressors of the type II
interfering mutants in either S. cerevisiae or S. pombe. Second,
since all G proteins contain the DX2G motif (4) in which the
type II mutation is localized, it would be useful to determine if
manipulation of this conserved aspartic acid in other G pro-
teins will constitute a general strategy for generating interfer-
ing mutants. Third, type I interfering mutants have been used
to dissect RAS function in mammalian systems (7, 54). Since
our genetic analyses in two yeast systems indicate that the type
I mutants do not completely abolish RAS functions, a conser-
vative interpretation of the effects of type I mutants in mam-
malian systems is warranted until similar mammalian studies
are carried out with type II interfering mutants. The ability of
the two forms of RAS mutants to interfere in a discriminatory
manner with RAS pathways suggests the interesting possibility
that the RAS effector is coupled with the upstream activator
with which RAS associates. The presently available repertoire
of RAS exchange factors isolated from mammalian cells (9, 10,
24, 34, 51, 61, 65) and the availability of these two forms of
interfering RAS mutants should allow us to test this possibility.
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